...
首页> 外文期刊>Saudi Pharmaceutical Journal >Green synthesis and biological evaluation of novel 5-fluorouracil derivatives as potent anticancer agents
【24h】

Green synthesis and biological evaluation of novel 5-fluorouracil derivatives as potent anticancer agents

机译:新型5-氟尿嘧啶衍生物的绿色合成与生物学评价为强抗抗癌剂

获取原文
   

获取外文期刊封面封底 >>

       

摘要

This study reports the formation of 5-FU co-crystals with four different pharmacologically safe co-formers; Urea, Thiourea, Acetanilide and Aspirin using methanol as a solvent. Two fabrication schemes were followed i.e., solid-state grinding protocol, in which API and co-formers were mixed through vigorous grinding while in the other method separate solutions of both the components were made and mixed together. The adopted approaches offer easy fabrication protocols, no temperature maintenance requirements, no need of expensive solvents, hardly available apparatus, isolation and purification of the desired products. In addition, there is no byproducts formation, In fact, a phenomenon embracing the requirements of green synthesis. Through FTIR analysis; for API the N H absorption frequency was recorded at 3409.02 cmsup?1/sup and that of C O was observed at 1647.77 cmsup?1/sup. These characteristics peaks of 5-FU were significantly shifted and recorded at 3499.40 cmsup?1/sup and 1649.62 cmsup?1/sup for 5-FU-Ac (3B) and 3496.39 cmsup?1/sup and 1659.30 cmsup?1/sup for 5-FU-As (4B) co-crystals for N H and C O groups respectively. The structural differences between API and co-crystals were further confirmed through PXRD analysis. The characteristic peak of 5-FU at 2θ = 28.79918supo/sup was significantly shifted in the graphs of co-crystals not only in position but also with respect to intensity and FWHM values. In addition, new peaks were also recorded in all the spectra of co-formers confirming the structural differences between API and co-formers. In addition, percent growth inhibition was also observed by all the co-crystals through MTT assay against HCT 116 colorectal cell lines in vitro . At four different concentrations; 25, 50, 100 and 200 μg/mL, slightly different trends of the effectiveness of API and co-crystals were observed. However; among all the co-crystal forms, 5-FU-thiourea co-crystals obtained through solution method (2B) proved to be the most effective growth inhibitor at all the four above mentioned concentrations.
机译:本研究报告了具有四种不同的药理学安全共生体的5-FU共晶体的形成;尿素,硫脲,乙酰硅氧烷和阿司匹林使用甲醇作为溶剂。遵循两种制造方案,即固态研磨方案,其中API和共置剂通过剧烈研磨而混合,而在其他方法中,将两种组分的单独溶液一起制成并混合在一起。采用的方法提供易于制造的协议,无需温度维护要求,不需要昂贵的溶剂,几乎不可用的设备,隔离和纯化所需产物。此外,没有副产品形成,其实是一种拥抱绿色合成要求的现象。通过FTIR分析;对于API,N H吸收频率以3409.02cm 1℃记录,并且在1647.77cm 1 中观察到C O的。 5-FU的这些特性峰值显着偏移并以3499.40cm 1℃的峰值记录,为5-fu-ac(3b)和3496.39cm 。 >α1和1659.30cm 1///p>分别用于NH和CO组的5-FU-AS(4B)共晶。通过PXRD分析进一步证实API和共晶之间的结构差异。在2θ= 28.79918处的5-fu的特征峰值在相对于强度和fwhm值的位置,在共晶体的图表中显着地移位。此外,还记录了新的峰的所有共同成型剂的光谱,证实了API和共置剂的结构差异。此外,还通过在体外抵抗HCT 116结肠直肠细胞系的MTT测定,通过MTT测定观察到百分比生长抑制百分比。四种不同的浓度;观察到25,50,100和200μg/ mL,观察到API和共晶的有效性的略有不同。然而;在所有共晶形式中,通过溶液方法(2b)获得的5-fu-thiourea官能团被证明是所有四种上述浓度的最有效的生长抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号